Evidence map›Paper›PMID 31242296›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.

Shruthi Ravimohan, Sara C Auld, Pholo Maenetje, Nelly Ratsela, Mandla Mlotshwa, Itai Ncube, Jonathan P Smith, Mboyo-Di-Tamba Vangu, Modulakgotla Sebe, Andrew Kossenkov and 5 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Perspectives for systems biology in the management of tuberculosis.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  13. Article
  14. A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Shruthi RavimohanDepartment of Medicine, Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Sara C AuldEmory University Rollins School of Public Health and School of Medicine, Atlanta, Georgia.
Pholo MaenetjeThe Aurum Institute, Johannesburg.
Nelly RatselaThe Aurum Institute, Johannesburg.
Mandla MlotshwaThe Aurum Institute, Johannesburg.
Itai NcubeThe Aurum Institute, Johannesburg.
Jonathan P SmithEmory University Rollins School of Public Health and School of Medicine, Atlanta, Georgia.
Mboyo-Di-Tamba VanguNuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, South Africa.
Modulakgotla SebeThe Aurum Institute, Johannesburg.
Andrew KossenkovThe Wistar Institute, Philadelphia, Pennsylvania.
Drew WeissmanDepartment of Medicine, Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Robert S WallisThe Aurum Institute, Johannesburg.
Gavin ChurchyardThe Aurum Institute, Johannesburg.
Hardy KornfeldDepartment of Medicine, University of Massachusetts Medical School, Worcester.
Gregory P BissonDepartment of Medicine, Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Aurum Institute · ZAUniversity of Pennsylvania · USEmory University · USSouth African Medical Research Council · ZAThe Wistar Institute · USUniversity of Massachusetts Chan Medical School · USUniversity of the Witwatersrand · ZA

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Institutional Clinical and Translational Science AwardKL2TR001879 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$13.7M
Rapid Immune Restoration and Lung Injury in HIV/TBR01AI120821 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BISSON, GREGORY P. · 2015 to 2019
$3.3M
Impact of HIV infection on early responses to TB exposureK23AI134182 · NIAID · EMORY UNIVERSITY · PI AULD, SARA · 2018 to 2023
$972k
NCATS NIH HHS KL2 TR001879NIAID NIH HHS K23 AI134182NIAID NIH HHS P30 AI045008NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI120821
6 · The paper itself

Abstract

backgroundImmune restoration on antiretroviral therapy (ART) can drive inflammation in people living with human immunodeficiency virus (HIV) who have pulmonary tuberculosis (TB), but its effects on the lungs have not been assessed. We evaluated associations between pulmonary inflammation, recovery of pathogen-specific CD4 T-cell function, and lung injury prior to and after ART initiation in adults with HIV and pulmonary TB.

methodsThis was a prospective cohort study in South Africa, following adults with HIV and pulmonary TB prior to and up to 48 weeks after ART initiation. Pulmonary-specific inflammation was defined as total glycolytic activity (TGA) on [18]F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) at baseline and 4 weeks after ART initiation. Spirometry, respiratory symptom tests, and flow cytometry were performed at the same times to assess lung involvement and the frequency of mycobacteria-specific CD4 T-cells. In addition, we evaluated lung function longitudinally up to 48 weeks after ART initiation.

resultsGreater lung TGA on FDG PET-CT was associated with worse lung function and respiratory symptoms prior to ART initiation, and nearly half of subjects experienced worsening lung inflammation and lung function at Week 4 of ART. Worsening Week 4 lung inflammation and pulmonary function were both associated with greater increases in pathogen-specific functional CD4 T-cell responses on ART, and early decreases in lung function were independently associated with persistently lower lung function months after TB treatment completion.

conclusionsIncreases in pulmonary inflammation and decreases in lung function are common on ART, relate to greater ART-mediated CD4 T-cell restoration, and are associated with the persistent impairment of lung function in individuals with HIV/TB.

Indexed as

HIV InfectionsLung InjuryTuberculosisAdultCD4 Lymphocyte CountHIVHumansPositron Emission Tomography Computed TomographyProspective StudiesSouth Africaantiretroviral therapyCD4 T-cell functionFDG positron emission tomography–computed tomography (PET-CT)HIV/tuberculosispulmonary function

Identifiers

PMID31242296
PMCPMC7156779
OpenAlexW2954063898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.